EGFR c.1636C>G ;(p.P546A)

Variant ID: 7-55231430-C-G

NM_005228.3(EGFR):c.1636C>G;(p.P546A)

This variant was identified in 3 publications

View GRCh38 version.




Publications:


Predicting response to enzalutamide and abiraterone in metastatic prostate cancer using whole-omics machine learning.

Nature Communications
de Jong, Anouk C AC; Danyi, Alexandra A; van Riet, Job J; de Wit, Ronald R; Sjöström, Martin M; Feng, Felix F; de Ridder, Jeroen J; Lolkema, Martijn P MP
Publication Date: 2023-04-08

Variant appearance in text: EGFR: P546A
PubMed Link: 37031196
Variant Present in the following documents:
  • 41467_2023_37647_MOESM4_ESM.xlsx, sheet 6
View BVdb publication page



Somatic mutations and copy number variations in breast cancers with heterogeneous HER2 amplification.

Molecular Oncology
Van Bockstal, Mieke R MR; Agahozo, Marie Colombe MC; van Marion, Ronald R; Atmodimedjo, Peggy N PN; Sleddens, Hein F B M HFBM; Dinjens, Winand N M WNM; Visser, Lindy L LL; Lips, Esther H EH; Wesseling, Jelle J; van Deurzen, Carolien H M CHM
Publication Date: 2020-04

Variant appearance in text: EGFR: 1636C>G
PubMed Link: 32058674
Variant Present in the following documents:
  • MOL2-14-671.pdf
View BVdb publication page



Hypoxia/HIF1α induces lapatinib resistance in ERBB2-positive breast cancer cells via regulation of DUSP2.

Oncotarget
Karakashev, Sergey V SV; Reginato, Mauricio J MJ
Publication Date: 2015-02-10

Variant appearance in text: ERBB: P546A
PubMed Link: 25596742
Variant Present in the following documents:
  • Main text
View BVdb publication page